{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7548,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-b3a4-71cc-8183-985590ab9557",
      "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
      "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
      "authorId": "maxcyte",
      "authorName": "MaxCyte",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "business_model",
      "function": "present_solution",
      "notes": "Uses the 'Razor/Razor Blade' business model framework.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/17",
      "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
      "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 16,
          "beatId": "e4f7a46b-9042-439c-bd19-663ca53403ca",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Business Model",
          "beatSlug": "sequoia-pitch-business-model",
          "evidence": "The business model is explained on pages 16-17.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b3a4-71cc-8183-985590ab9557",
      "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
      "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
      "authorId": "maxcyte",
      "authorName": "MaxCyte",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide contrasts a traditional, lengthy development process with the accelerated VLx-enabled approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/18",
      "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
      "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b3a4-71cc-8183-985590ab9557",
      "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
      "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
      "authorId": "maxcyte",
      "authorName": "MaxCyte",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a timeline-based comparison to highlight time savings (6+ months vs 1-2 months).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/19",
      "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
      "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b3a4-71cc-8183-985590ab9557",
      "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
      "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
      "authorId": "maxcyte",
      "authorName": "MaxCyte",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process diagram to illustrate the workflow context for the company's technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/20",
      "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
      "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-20",
      "loopMatches": [
        {
          "to": 21,
          "from": 20,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "41f99638-2ab7-4bc5-8e96-09ca064b209b",
          "evidence": "The closing ask section implies that now is the right time to invest.",
          "position": 2,
          "objective": "Why is now the right time to invest in MaxCyte?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.5,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b3a4-71cc-8183-985590ab9557",
      "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
      "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
      "authorId": "maxcyte",
      "authorName": "MaxCyte",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/21",
      "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
      "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-21",
      "loopMatches": [
        {
          "to": 21,
          "from": 20,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "41f99638-2ab7-4bc5-8e96-09ca064b209b",
          "evidence": "The closing ask section implies that now is the right time to invest.",
          "position": 2,
          "objective": "Why is now the right time to invest in MaxCyte?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.5,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 21,
          "beatId": "099b16d1-851c-4c93-9cff-a4e90fb2b444",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "The Ask",
          "beatSlug": "sequoia-pitch-the-ask",
          "evidence": "The ask is presented on page 21.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/jeTR9ci5RfFNFxqLoEOGxS8uDQZOrQsDJUHG2OGKp3E/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hZTg2Y2I3MzlmY2NhYThmMWYzYjM2N2FmMTAxZTdiYS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/1",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 1,
          "beatId": "0ba5add4-09fc-4e9e-9b81-e8059c5c61ed",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-1",
          "evidence": "Introduction and disclaimer",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/-F0LGa_lXiu2nektDhAzgBToyLbFSbCQpboLAIpGh8U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hZTg2Y2I3MzlmY2NhYThmMWYzYjM2N2FmMTAxZTdiYS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/3fjUWVy6SfdFTeQtetz6rJg_7f8X1UDmWqLI9kfhuuA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hZTg2Y2I3MzlmY2NhYThmMWYzYjM2N2FmMTAxZTdiYS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/9no6stEqrJkeyzkI3yJpjZj3PVYHxYIMQXI59x1DEfc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hZTg2Y2I3MzlmY2NhYThmMWYzYjM2N2FmMTAxZTdiYS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/2",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 1,
          "beatId": "0ba5add4-09fc-4e9e-9b81-e8059c5c61ed",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-1",
          "evidence": "Introduction and disclaimer",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 3,
      "slideType": "timeline",
      "function": "summarize",
      "notes": "The slide uses a matrix-like structure to compare financial metrics over time, with donut charts for mix and tables for assets/ROTCE.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/3",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "e06687fa-72a3-49e9-88c3-dcab40cd0770",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-3",
          "evidence": "Overview of Morgan Stanley's transformation and key metrics",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 4,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide highlights Morgan Stanley's market position and asset growth.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/4",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-4",
      "loopMatches": [
        {
          "to": 5,
          "from": 4,
          "name": "Benchmark Gap",
          "slug": "39-benchmark-gap",
          "bestFor": "Performance improvement, competitive analysis, target setting",
          "matchId": "77dc6ce9-e068-4d60-9baa-53355cab5f09",
          "evidence": "Comparison of key metrics",
          "position": 0,
          "objective": "Highlighting Morgan Stanley's performance relative to peers",
          "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity",
          "confidence": 0.6,
          "description": "Compare performance against best-in-class to quantify the opportunity"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "e06687fa-72a3-49e9-88c3-dcab40cd0770",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-3",
          "evidence": "Overview of Morgan Stanley's transformation and key metrics",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 5,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart shows revenue growth across three regions (Americas, EMEA, Asia) over three time points (2010, 2018, 2023).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/5",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-5",
      "loopMatches": [
        {
          "to": 5,
          "from": 4,
          "name": "Benchmark Gap",
          "slug": "39-benchmark-gap",
          "bestFor": "Performance improvement, competitive analysis, target setting",
          "matchId": "77dc6ce9-e068-4d60-9baa-53355cab5f09",
          "evidence": "Comparison of key metrics",
          "position": 0,
          "objective": "Highlighting Morgan Stanley's performance relative to peers",
          "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity",
          "confidence": 0.6,
          "description": "Compare performance against best-in-class to quantify the opportunity"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "e06687fa-72a3-49e9-88c3-dcab40cd0770",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Is",
          "beatSlug": "sparkline-what-is-3",
          "evidence": "Overview of Morgan Stanley's transformation and key metrics",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 6,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "The diagram uses a hub-and-spoke circular flow model to represent the firm's central role in the ecosystem.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/6",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-6",
      "loopMatches": [
        {
          "to": 7,
          "from": 6,
          "name": "So What Cascade",
          "slug": "41-so-what-cascade",
          "bestFor": "Data presentations, executive summaries, driving to recommendations",
          "matchId": "e7149ef4-94de-4064-88eb-f2e298b443a3",
          "evidence": "Key messages and team bio",
          "position": 1,
          "objective": "Explaining the implications of Morgan Stanley's integrated firm strategy",
          "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)",
          "confidence": 0.6,
          "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "4008d9ec-6d0a-4e8d-9d7e-36b7350eee8a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Could Be",
          "beatSlug": "sparkline-what-could-be-2",
          "evidence": "Key messages, team bio, and financial capital strategy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "summarize",
      "notes": "The slide uses a hierarchical layout to represent the firm's leadership structure from the top down.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/7",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-7",
      "loopMatches": [
        {
          "to": 7,
          "from": 6,
          "name": "So What Cascade",
          "slug": "41-so-what-cascade",
          "bestFor": "Data presentations, executive summaries, driving to recommendations",
          "matchId": "e7149ef4-94de-4064-88eb-f2e298b443a3",
          "evidence": "Key messages and team bio",
          "position": 1,
          "objective": "Explaining the implications of Morgan Stanley's integrated firm strategy",
          "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)",
          "confidence": 0.6,
          "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "4008d9ec-6d0a-4e8d-9d7e-36b7350eee8a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Could Be",
          "beatSlug": "sparkline-what-could-be-2",
          "evidence": "Key messages, team bio, and financial capital strategy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 8,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "SCB stands for Stress Capital Buffer. The slide highlights capital efficiency and shareholder return.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/8",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "4008d9ec-6d0a-4e8d-9d7e-36b7350eee8a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Could Be",
          "beatSlug": "sparkline-what-could-be-2",
          "evidence": "Key messages, team bio, and financial capital strategy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 9,
      "slideType": "kpi_overview",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/9",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "4008d9ec-6d0a-4e8d-9d7e-36b7350eee8a",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "What Could Be",
          "beatSlug": "sparkline-what-could-be-2",
          "evidence": "Key messages, team bio, and financial capital strategy",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 10,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/10",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 10,
          "beatId": "227e3603-c6c4-484e-b00d-26fa5f36d3ae",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "New Bliss",
          "beatSlug": "sparkline-new-bliss",
          "evidence": "Conclusion and end notes",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 11,
      "slideType": "appendix_disclosure",
      "function": "appendix",
      "notes": "Includes reconciliation table for Net Revenues and Pre-Tax Profit adjustments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/11",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 10,
          "beatId": "227e3603-c6c4-484e-b00d-26fa5f36d3ae",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "New Bliss",
          "beatSlug": "sparkline-new-bliss",
          "evidence": "Conclusion and end notes",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 12,
      "slideType": "appendix_disclosure",
      "function": "appendix",
      "notes": "Standard financial disclosure page for Morgan Stanley investor presentation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/12",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 10,
          "beatId": "227e3603-c6c4-484e-b00d-26fa5f36d3ae",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "New Bliss",
          "beatSlug": "sparkline-new-bliss",
          "evidence": "Conclusion and end notes",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "docSlug": "ae86cb739fccaa8f1f3b367af101e7ba",
      "documentTitle": "Morgan Stanley | Investor Presentation Deck | 13 slides",
      "authorId": "morgan-stanley",
      "authorName": "Morgan Stanley",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.3333334,
      "pageNumber": 13,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b47c-73fc-b8ad-04dcb0612ca0/13",
      "deckHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0",
      "deckAnchorHref": "/decks/019de076-b47c-73fc-b8ad-04dcb0612ca0#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 10,
          "beatId": "227e3603-c6c4-484e-b00d-26fa5f36d3ae",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "New Bliss",
          "beatSlug": "sparkline-new-bliss",
          "evidence": "Conclusion and end notes",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Features a stylized anatomical illustration highlighting the liver.",
      "imagePath": "https://imgproxy.kitesheet.com/WmjbxWLPPuyjEle7XofQWjaO34q6NMOyo8NDWF1XbP8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yM2Y5YjJkZmIxNGU0OTJhZTU3ODBiNmQxOWU3NTJlNC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/1",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/g_6L6Qym9pVNqkRcHPpM9OjmoOl3G3Rv58iT5JsU8Vo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yM2Y5YjJkZmIxNGU0OTJhZTU3ODBiNmQxOWU3NTJlNC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/CPGy8Ot5T4Ggm9-rFwCZht2wWXle47zVsBbEVE7cI6o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yM2Y5YjJkZmIxNGU0OTJhZTU3ODBiNmQxOWU3NTJlNC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/KiKGhAT-BcaMRSw3E88j1U3TG5Qk2xixy_YXO2VePbA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yM2Y5YjJkZmIxNGU0OTJhZTU3ODBiNmQxOWU3NTJlNC9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/2",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/3",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 3,
          "beatId": "2cdd1f08-1e60-41d6-959f-f81f5db2067c",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "Slide 3 highlights the strong leadership team",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/4",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-4",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 4,
          "beatId": "343e220c-2ea7-4fa7-b93e-eece465c32e9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 4 and 5 introduce the target conditions and the pipeline",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/5",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-5",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 4,
          "beatId": "343e220c-2ea7-4fa7-b93e-eece465c32e9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 4 and 5 introduce the target conditions and the pipeline",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style layout to map clinical phases to specific time periods.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/6",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-6",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a medical illustration of the liver to highlight the target organ.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/7",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-7",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a standard comparison table format to contrast a competitor (Resmetirom) with the company's own asset (DA-1241).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/8",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "aaa7b418-9181-47ba-b6b2-b63828815fff",
          "evidence": "Slides 8-9 discuss DA-1241's competitive differentiation",
          "position": 0,
          "objective": "How does DA-1241 differentiate from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        },
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The diagram shows a biological pathway from steatosis to steatohepatitis to fibrosis, highlighting the role of GPR119 activation in modulating cellular responses.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/9",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "aaa7b418-9181-47ba-b6b2-b63828815fff",
          "evidence": "Slides 8-9 discuss DA-1241's competitive differentiation",
          "position": 0,
          "objective": "How does DA-1241 differentiate from existing treatments?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.6,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        },
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide shows two heatmaps (17 inflammation genes, 22 stellate cell activation genes) and a biological pathway diagram.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/10",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-10",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes specific study references and definitions for abbreviations like GPR119, MASH, and GLP-1.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/11",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-11",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b515-770b-a5e9-c449fc01e3f7",
      "docSlug": "23f9b2dfb14e492ae5780b6d19e752e4",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "other",
      "function": "analyze_data",
      "notes": "The slide presents 10 distinct bar charts comparing Control, DA, DA+DPP4i, and DPP4i groups, with statistical significance markers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b515-770b-a5e9-c449fc01e3f7/12",
      "deckHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7",
      "deckAnchorHref": "/decks/019de076-b515-770b-a5e9-c449fc01e3f7#slide-12",
      "loopMatches": [
        {
          "to": 24,
          "from": 4,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "f32f8b98-1128-49fc-a44e-5a106180640e",
          "evidence": "The entire deck addresses the question, with a clear 'why' ( Slides 4-24)",
          "position": 1,
          "objective": "Why is NeuroBo Pharmaceuticals well-positioned to address MASH and obesity?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "fc2a383c-968e-4c6a-836f-347c2e1bb09a",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-14 detail the solution, including DA-1241 and its competitive differentiation",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}